Home › Research › Topics › plasma-soluble
plasma-soluble
3 studies tagged plasma-soluble, dated 2022-04-01 to 2025-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer's disease 2025-04-01
- Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals 2024-06-28
- Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease 2022-04-01
Studies
3 studies carry this tag.
Date range
2022 to 2025
Top journals
- Alzheimer's research & therapy 1
- Molecular psychiatry 1
- Science advances 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
53/100
Loss-of-function mutation of triggering receptor expressed on myeloid cell 2 (TREM2) is associated with increased risks for Alzheimer's disease (AD).
-
Soluble plasma Aβ42/40 ratio is the most robust biomarker to discriminate between AD patients and CN individuals, as it normalizes for the number of NDEVs.
-
CD22 has been suggested to contribute to Alzheimer's disease (AD) pathogenesis by inhibiting microglial amyloid β (Aβ) phagocytosis.